AMRZ
Amrize Ltd
AMRZ's fundamentals are mixed: it turned 8.8% of its revenue into free cash flow, but earnings per share fell 11%. At 18x earnings, it's trading below its usual 23x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
AMRZ Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
AMRZ's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
AMRZ PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 17x | $40.83 | — |
| Current | 18x | $40.83 | — |
| Cheap | 19x | $41.78 | +2.3% |
| Fair | 23x | $50.15 | +23% |
| Expensive | 26x | $56.77 | +39% |
Historical ranges are pointers, not guarantees.
AMRZ's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 17x.
AMRZ Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect AMRZ's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
AMRZ Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.44 | +10% |
| Q3 2026 | $2.21 | -11% |
| Q2 2026 | $2.17 | -12% |
| Q1 2026 | $2.09 | -18% |
| Q4 2025 | $2.20 | -14% |
| Q3 2025 | $2.49 | +30% |
AMRZ earned $2.21 per share over the past year, down 11% from the year before.
AMRZ Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.8B | +2.6% |
| Q2 2026 | $3.5B | +8.5% |
| Q1 2026 | $2.2B | +4.7% |
| Q4 2025 | $2.8B | -0.4% |
| Q3 2025 | $3.7B | +6.6% |
| Q2 2025 | $3.2B | -0.7% |
| Q1 2025 | $2.1B | -3.9% |
| Q4 2024 | $2.8B | -2.2% |
AMRZ's revenue has held roughly level: $3.8B last quarter, up 2.6% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -0.1 points |
| Q2 2026 | 20% | -0.4 points |
| Q1 2026 | -3.5% | -2.7 points |
| Q4 2025 | 17% | -0.7 points |
| Q3 2025 | 21% | -3.3 points |
| Q2 2025 | 21% | -2.5 points |
| Q1 2025 | -0.8% | -3.6 points |
| Q4 2024 | 17% | +3.6 points |
AMRZ's operating margin was 21% last quarter, about level with the same quarter a year ago.
AMRZ Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $431M | -36% |
| Q1 2026 | -$1.2B | -$101M |
| Q4 2025 | $1.6B | +0.2% |
| Q3 2025 | $669M | +66% |
| Q1 2025 | -$1.1B | -$288M |
| Q4 2024 | $1.6B | +18% |
AMRZ generated $1.1B in free cash flow over the past year, down 34% from the year before.
AMRZ Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.0x | Moderate |
| Q2 2026 | 2.0x | Healthy |
| Q1 2026 | 1.9x | Healthy |
| Q4 2025 | -0.7x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 2.0x | Moderate |
| Q4 2024 | 1.3x | Healthy |
AMRZ's net debt is about 2.0 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
AMRZ Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 36.7 | Neutral |
AMRZ's weekly RSI is 40 (neutral) and its Stochastic is 37 (neutral).
AMRZ PE vs Basic Materials Sector
| Metric | AMRZ | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 19x | 0.6% below |
| PE % | 11 | 3 | 8 pts above |
AMRZ is trading at 18x earnings, in line with the Basic Materials sector's median of 19x.
AMRZ Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.1 | 4.3% above |
| 20 week MA | $43.5 | 6.2% below |
| 50 week MA | $50.8 | 20% below |
AMRZ has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 20% below its 50-week average.
AMRZ Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $49.0 | $55.8 | +14% |
| 2026 YTD | $55.8 | $40.8 | -27% |
AMRZ has finished every year since 2025 higher, and it's down 27% so far in 2026.